Pyruvate Oxidase as a Key Determinant of Pneumococcal Viability during Transcytosis across Brain Endothelium.
Streptococcus pneumoniae
acid tolerance response
blood-brain barrier
endocytic pathway
pyruvate oxidase
two-component system
Journal
Journal of bacteriology
ISSN: 1098-5530
Titre abrégé: J Bacteriol
Pays: United States
ID NLM: 2985120R
Informations de publication
Date de publication:
19 11 2021
19 11 2021
Historique:
pubmed:
5
10
2021
medline:
21
12
2021
entrez:
4
10
2021
Statut:
ppublish
Résumé
Streptococcus pneumoniae invades a myriad of host tissues following efficient breaching of cellular barriers. However, strategies adopted by pneumococcus for evasion of host intracellular defenses governing successful transcytosis across host cellular barriers remain elusive. In this study, using brain endothelium as a model host barrier, we observed that pneumococcus containing endocytic vacuoles (PCVs), formed following S. pneumoniae internalization into brain microvascular endothelial cells (BMECs), undergo early maturation and acidification, with a major subset acquiring lysosome-like characteristics. Exploration of measures that would preserve pneumococcal viability in the lethal acidic pH of these lysosome-like vacuoles revealed a critical role of the two-component system response regulator, CiaR, which was previously implicated in induction of acid tolerance response. Pyruvate oxidase (SpxB), a key sugar-metabolizing enzyme that catalyzes oxidative decarboxylation of pyruvate to acetyl phosphate, was found to contribute to acid stress tolerance, presumably via acetyl phosphate-mediated phosphorylation and activation of CiaR, independent of its cognate kinase CiaH. Hydrogen peroxide, the by-product of an SpxB-catalyzed reaction, was also found to improve pneumococcal intracellular survival by oxidative inactivation of lysosomal cysteine cathepsins, thus compromising the degradative capacity of the host lysosomes. As expected, a Δ
Identifiants
pubmed: 34606370
doi: 10.1128/JB.00439-21
pmc: PMC8604078
doi:
Substances chimiques
Pyruvate Oxidase
EC 1.2.3.3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0043921Références
PLoS Pathog. 2020 Aug 13;16(8):e1008761
pubmed: 32790758
PLoS Pathog. 2020 Nov 20;16(11):e1009016
pubmed: 33216805
Free Radic Biol Med. 2011 Nov 1;51(9):1656-65
pubmed: 21835240
J Exp Med. 2001 May 7;193(9):1067-76
pubmed: 11342591
Infect Immun. 2010 May;78(5):2108-16
pubmed: 20160017
J Biol Chem. 2013 Aug 23;288(34):24518-27
pubmed: 23843460
J Bacteriol. 2004 Aug;186(16):5258-66
pubmed: 15292127
Mucosal Immunol. 2014 Mar;7(2):249-56
pubmed: 23820749
mBio. 2018 Jan 16;9(1):
pubmed: 29339428
Semin Immunopathol. 2010 Dec;32(4):415-30
pubmed: 20803017
Bioessays. 2013 Oct;35(10):900-12
pubmed: 23881848
Microb Pathog. 2001 Jan;30(1):19-28
pubmed: 11162182
Microbiology (Reading). 2005 Dec;151(Pt 12):3935-3946
pubmed: 16339938
Histochem Cell Biol. 2008 Apr;129(4):389-406
pubmed: 18259769
Biochim Biophys Acta. 1960 Apr 22;39:508-18
pubmed: 14413322
Infect Immun. 2004 Jun;72(6):3584-91
pubmed: 15155668
ACS Synth Biol. 2015 Mar 20;4(3):228-39
pubmed: 24845455
Int J Med Microbiol. 2015 Jan;305(1):157-69
pubmed: 25543170
J Immunol. 2004 Jan 15;172(2):1169-76
pubmed: 14707093
Biochim Biophys Acta. 2012 Jan;1824(1):68-88
pubmed: 22024571
FEBS Lett. 2006 Mar 20;580(7):1817-21
pubmed: 16516202
Infect Immun. 2005 Aug;73(8):4653-67
pubmed: 16040978
ACS Chem Biol. 2013 Mar 15;8(3):535-42
pubmed: 23256573
Infect Immun. 2010 Feb;78(2):704-15
pubmed: 19948837
BMC Infect Dis. 2020 Apr 20;20(1):292
pubmed: 32312231
J Clin Invest. 2016 Aug 1;126(8):2821-6
pubmed: 27348589
Front Microbiol. 2017 Oct 12;8:1983
pubmed: 29075247
Microbiology (Reading). 2020 Apr;166(4):411-421
pubmed: 32553069
Microbes Infect. 2007 Aug;9(10):1176-87
pubmed: 17720603
mBio. 2014 Jul 01;5(4):e00984-14
pubmed: 24987087
Front Microbiol. 2015 Jan 15;5:772
pubmed: 25642214
PLoS Pathog. 2018 Jun 8;14(6):e1007118
pubmed: 29883472
Science. 2004 Jun 18;304(5678):1805-7
pubmed: 15205533
PLoS Pathog. 2013;9(6):e1003394
pubmed: 23762025
Nat Microbiol. 2018 May;3(5):600-610
pubmed: 29662129
Laryngoscope. 1997 May;107(5):640-7
pubmed: 9149167
J Clin Invest. 2002 Jan;109(1):19-27
pubmed: 11781347
Annu Rev Biochem. 1983;52:711-60
pubmed: 6137189
Nat Cell Biol. 2001 Jul;3(7):675-8
pubmed: 11433300
J Bacteriol. 2007 Feb;189(3):1025-35
pubmed: 17114262
Microbiology (Reading). 2006 May;152(Pt 5):1307-1317
pubmed: 16622048
Nature. 2005 Dec 1;438(7068):597-604
pubmed: 16319879
Front Microbiol. 2017 Jul 19;8:1354
pubmed: 28769913
Mol Microbiol. 1996 Feb;19(4):803-13
pubmed: 8820650
J Clin Invest. 2012 Jun;122(6):2208-20
pubmed: 22622042
Sci Rep. 2016 Nov 15;6:36996
pubmed: 27845429
Cell. 1999 Apr 30;97(3):339-47
pubmed: 10319814
Infect Immun. 2000 Jul;68(7):3990-7
pubmed: 10858213
Infect Immun. 2017 Dec 19;86(1):
pubmed: 29061707
J Clin Invest. 1998 Jul 15;102(2):347-60
pubmed: 9664076
Diabetes Care. 2004 Jan;27(1):70-6
pubmed: 14693969
Nat Commun. 2019 Aug 2;10(1):3493
pubmed: 31375698
J Bacteriol. 2003 Dec;185(23):6815-25
pubmed: 14617646
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4033-8
pubmed: 15753315
J Leukoc Biol. 2006 Jun;79(6):1214-25
pubmed: 16543403
Infect Immun. 2006 Sep;74(9):5058-66
pubmed: 16926397
Trends Microbiol. 2013 Apr;21(4):187-95
pubmed: 23415028
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3421-30
pubmed: 26080406
Traffic. 2012 Dec;13(12):1565-88
pubmed: 22901006
Front Microbiol. 2017 Feb 20;8:224
pubmed: 28265264
mBio. 2016 Apr 12;7(2):e00020-16
pubmed: 27073088
Microbes Infect. 2015 Nov-Dec;17(11-12):766-71
pubmed: 26327296
J Bacteriol. 2015 Mar;197(5):807-18
pubmed: 25512311
Mol Microbiol. 2005 Feb;55(3):778-87
pubmed: 15661003
J Mol Microbiol Biotechnol. 2011 Apr;20(2):96-104
pubmed: 21422763
EMBO J. 2011 Aug 31;30(17):3481-500
pubmed: 21878991
Cell Microbiol. 2008 Jun;10(6):1209-20
pubmed: 18363881
Respiration. 1986;50 Suppl 1:31-42
pubmed: 3809741
J Bacteriol. 2009 May;191(10):3301-10
pubmed: 19286803
Antimicrob Agents Chemother. 2004 Dec;48(12):4673-9
pubmed: 15561843
PLoS One. 2013 Jul 16;8(7):e68408
pubmed: 23874613
N Engl J Med. 1999 Dec 16;341(25):1906-12
pubmed: 10601511
IDCases. 2016 Apr 12;4:56-8
pubmed: 27144125
Microbiology (Reading). 2007 Jul;153(Pt 7):2289-2303
pubmed: 17600073
Microbiology (Reading). 2008 May;154(Pt 5):1300-1308
pubmed: 18451038
Int J Med Microbiol. 2018 Aug;308(6):722-737
pubmed: 29221986
Science. 2004 Nov 5;306(5698):1037-40
pubmed: 15528445
mBio. 2016 Mar 22;7(2):e01792
pubmed: 27006456
PLoS Pathog. 2018 Jul 16;14(7):e1007168
pubmed: 30011336
EMBO J. 2012 Feb 15;31(4):932-44
pubmed: 22157818
Semin Immunopathol. 2018 Nov;40(6):555-565
pubmed: 30182191
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33561-33569
pubmed: 33376222
Mol Microbiol. 2007 Oct;66(1):110-26
pubmed: 17725562
J Bacteriol. 2006 Mar;188(5):1959-68
pubmed: 16484208
Front Cell Infect Microbiol. 2020 Nov 03;10:590682
pubmed: 33224900
J Exp Med. 2005 Jul 18;202(2):209-15
pubmed: 16009720
Biochim Biophys Acta. 2000 Mar 7;1477(1-2):98-111
pubmed: 10708852
Cell Host Microbe. 2016 Sep 14;20(3):307-317
pubmed: 27593514
Front Microbiol. 2017 Nov 23;8:2284
pubmed: 29218036
Sci Rep. 2020 Nov 3;10(1):18932
pubmed: 33144660
Curr Biol. 2004 May 4;14(9):806-11
pubmed: 15120074
PLoS Pathog. 2016 Oct 19;12(10):e1005951
pubmed: 27760231
Biochim Biophys Acta. 2011 May;1813(5):784-801
pubmed: 21277337